BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 36594082)

  • 21. Tumor-derived exosomal microRNA-106b-5p activates EMT-cancer cell and M2-subtype TAM interaction to facilitate CRC metastasis.
    Yang C; Dou R; Wei C; Liu K; Shi D; Zhang C; Liu Q; Wang S; Xiong B
    Mol Ther; 2021 Jun; 29(6):2088-2107. PubMed ID: 33571679
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Therapeutic potential of anti-VEGF receptor 2 therapy targeting for M2-tumor-associated macrophages in colorectal cancer.
    Min AKT; Mimura K; Nakajima S; Okayama H; Saito K; Sakamoto W; Fujita S; Endo H; Saito M; Saze Z; Momma T; Ohki S; Kono K
    Cancer Immunol Immunother; 2021 Feb; 70(2):289-298. PubMed ID: 32705303
    [TBL] [Abstract][Full Text] [Related]  

  • 23. CX3CR1 Acts as a Protective Biomarker in the Tumor Microenvironment of Colorectal Cancer.
    Yue Y; Zhang Q; Sun Z
    Front Immunol; 2021; 12():758040. PubMed ID: 35140706
    [TBL] [Abstract][Full Text] [Related]  

  • 24. MFHAS1 promotes colorectal cancer progress by regulating polarization of tumor-associated macrophages via STAT6 signaling pathway.
    Chen W; Xu Y; Zhong J; Wang H; Weng M; Cheng Q; Wu Q; Sun Z; Jiang H; Zhu M; Ren Y; Xu P; Chen J; Miao C
    Oncotarget; 2016 Nov; 7(48):78726-78735. PubMed ID: 27783989
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Gut microbiota-stimulated cathepsin K secretion mediates TLR4-dependent M2 macrophage polarization and promotes tumor metastasis in colorectal cancer.
    Li R; Zhou R; Wang H; Li W; Pan M; Yao X; Zhan W; Yang S; Xu L; Ding Y; Zhao L
    Cell Death Differ; 2019 Nov; 26(11):2447-2463. PubMed ID: 30850734
    [TBL] [Abstract][Full Text] [Related]  

  • 26. S100A9 promotes tumor-associated macrophage for M2 macrophage polarization to drive human liver cancer progression: An in vitro study.
    Yang LF; Zhang ZB; Wang L
    Kaohsiung J Med Sci; 2023 Apr; 39(4):345-353. PubMed ID: 36807724
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma membrane proteomics identifies bone marrow stromal antigen 2 as a potential therapeutic target in endometrial cancer.
    Yokoyama T; Enomoto T; Serada S; Morimoto A; Matsuzaki S; Ueda Y; Yoshino K; Fujita M; Kyo S; Iwahori K; Fujimoto M; Kimura T; Naka T
    Int J Cancer; 2013 Jan; 132(2):472-84. PubMed ID: 22729361
    [TBL] [Abstract][Full Text] [Related]  

  • 28. SPOCK1 and POSTN are valuable prognostic biomarkers and correlate with tumor immune infiltrates in colorectal cancer.
    Gan C; Li M; Lu Y; Peng G; Li W; Wang H; Peng Y; Hu Q; Wei W; Wang F; Liu L; Zhao Q
    BMC Gastroenterol; 2023 Jan; 23(1):4. PubMed ID: 36611136
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Tumor-derived exosomal miR-934 induces macrophage M2 polarization to promote liver metastasis of colorectal cancer.
    Zhao S; Mi Y; Guan B; Zheng B; Wei P; Gu Y; Zhang Z; Cai S; Xu Y; Li X; He X; Zhong X; Li G; Chen Z; Li D
    J Hematol Oncol; 2020 Nov; 13(1):156. PubMed ID: 33213490
    [TBL] [Abstract][Full Text] [Related]  

  • 30. EZH2 Inhibitors Suppress Colorectal Cancer by Regulating Macrophage Polarization in the Tumor Microenvironment.
    Li C; Song J; Guo Z; Gong Y; Zhang T; Huang J; Cheng R; Yu X; Li Y; Chen L; Ma X; Sun Y; Wang Y; Xue L
    Front Immunol; 2022; 13():857808. PubMed ID: 35432300
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Up-regulation of bone marrow stromal protein 2 (BST2) in breast cancer with bone metastasis.
    Cai D; Cao J; Li Z; Zheng X; Yao Y; Li W; Yuan Z
    BMC Cancer; 2009 Apr; 9():102. PubMed ID: 19338666
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Astragalus mongholicus Bunge-Curcuma aromatica Salisb. suppresses growth and metastasis of colorectal cancer cells by inhibiting M2 macrophage polarization via a Sp1/ZFAS1/miR-153-3p/CCR5 regulatory axis.
    Gu J; Sun R; Tang D; Liu F; Chang X; Wang Q
    Cell Biol Toxicol; 2022 Aug; 38(4):679-697. PubMed ID: 35072892
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Tumor-associated macrophage infiltration and prognosis in colorectal cancer: systematic review and meta-analysis.
    Li J; Li L; Li Y; Long Y; Zhao Q; Ouyang Y; Bao W; Gong K
    Int J Colorectal Dis; 2020 Jul; 35(7):1203-1210. PubMed ID: 32303831
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The active fraction of Garcinia yunnanensis suppresses the progression of colorectal carcinoma by interfering with tumorassociated macrophage-associated M2 macrophage polarization in vivo and in vitro.
    Sui H; Tan H; Fu J; Song Q; Jia R; Han L; Lv Y; Zhang H; Zheng D; Dong L; Wang S; Li Q; Xu H
    FASEB J; 2020 Jun; 34(6):7387-7403. PubMed ID: 32283574
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor-associated macrophages in colorectal cancer metastasis: molecular insights and translational perspectives.
    Hou S; Zhao Y; Chen J; Lin Y; Qi X
    J Transl Med; 2024 Jan; 22(1):62. PubMed ID: 38229160
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aberrant regulation of the BST2 (Tetherin) promoter enhances cell proliferation and apoptosis evasion in high grade breast cancer cells.
    Sayeed A; Luciani-Torres G; Meng Z; Bennington JL; Moore DH; Dairkee SH
    PLoS One; 2013; 8(6):e67191. PubMed ID: 23840623
    [TBL] [Abstract][Full Text] [Related]  

  • 37. NLRP7 deubiquitination by USP10 promotes tumor progression and tumor-associated macrophage polarization in colorectal cancer.
    Li B; Qi ZP; He DL; Chen ZH; Liu JY; Wong MW; Zhang JW; Xu EP; Shi Q; Cai SL; Sun D; Yao LQ; Zhou PH; Zhong YS
    J Exp Clin Cancer Res; 2021 Apr; 40(1):126. PubMed ID: 33838681
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Expression of BTS-2 Enhances Cell Growth and Invasiveness in Renal Cell Carcinoma.
    Pham QT; Oue N; Yamamoto Y; Shigematsu Y; Sekino Y; Sakamoto N; Sentani K; Uraoka N; Tiwari M; Yasui W
    Anticancer Res; 2017 Jun; 37(6):2853-2860. PubMed ID: 28551621
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune-related gene-based prognostic index for predicting survival and immunotherapy outcomes in colorectal carcinoma.
    Liang Z; Sun R; Tu P; Liang Y; Liang L; Liu F; Bian Y; Yin G; Zhao F; Jiang M; Gu J; Tang D
    Front Immunol; 2022; 13():944286. PubMed ID: 36591255
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Tumor-derived immunoglobulin like transcript 5 induces suppressive immunocyte infiltration in colorectal cancer.
    Shi W; Zhang F; Chen X; Wang S; Zhang H; Yang Z; Wang G; Zheng Y; Han Y; Sun Y; Gao A
    Cancer Sci; 2022 Jun; 113(6):1939-1954. PubMed ID: 35377522
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.